SARS CoV 2 News and Research

RSS

Researchers explore the power of podcasts in fighting infectious disease misinformation

With legacy media cutting staff in the face of unprecedented financial challenges and critical science and health information scattered among unfamiliar digital platforms, how can people keep up with medical issues that might affect them?

27 Nov 2024

WHO and partners announce grants to boost pathogen genomic surveillance

The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to improve capacities in pathogen genomic surveillance.

26 Nov 2024

Boosters cut long COVID risk significantly

Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.

25 Nov 2024

Barcelona launches world’s first joint program on evolutionary medical genomics

Three research institutions in Barcelona have teamed up to launch the world's first Joint Program on Evolutionary Medical Genomics.

22 Nov 2024

Researchers uncover hidden roles of accessory genes in SARS-CoV-2

Viruses are lean, mean, infection machines. Their genomes are tiny, usually limited to a handful of absolutely essential genes, and they shed extra genomic deadweight extremely fast.

20 Nov 2024

New approach to stabilize RSV protein could lead to better vaccines

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia and even death.

20 Nov 2024

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

SARS-CoV-2 disrupts cholesterol metabolism by using its ORF3a protein to sequester cholesterol in lysosomes, reducing BMP levels and optimizing viral survival. This novel mechanism offers insights into long-term metabolic complications of COVID-19.

19 Nov 2024

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.

18 Nov 2024

Genomic surveillance could revolutionize the fight against antimicrobial resistance

During the COVID-19 pandemic, genomic surveillance proved vital in helping understand the evolution and spread of the SARS-CoV-2 virus.

15 Nov 2024

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.

15 Nov 2024

Pandemic linked to 16% rise in babies born with heart defects

The proportion of babies born with a congenital heart abnormality increased by 16 per cent after the first year of the pandemic, according to research at City St George's, University of London and published today in Ultrasound in Obstetrics and Gynecology.

15 Nov 2024

Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies

AI-human collaboration in a "Virtual Lab" successfully designs and experimentally validates nanobodies with enhanced binding to SARS-CoV-2 variants, offering a novel approach to interdisciplinary research.

14 Nov 2024

FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality.

14 Nov 2024

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase results suggest potential benefits.

13 Nov 2024

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Researchers provide a global overview of COVID-19 vaccination programs among the elderly.

13 Nov 2024

Next-generation metagenomic sequencing test quickly detects any kind of pathogen

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen.

12 Nov 2024

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

Research indicates the Pfizer-BioNTech vaccine effectively reduces MIS-C incidence in children, supporting vaccination as a critical public health measure.

12 Nov 2024

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Research shows prenatal exposure to SARS-CoV-2 linked to slight regulatory behavior improvements in infants, but no significant neurodevelopmental impacts.

12 Nov 2024

AI tool enhances diagnosis of long COVID in electronic health records

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can encompass a litany of enduring symptoms, including fatigue, chronic cough, and brain fog after infection from SARS-CoV-2.

8 Nov 2024

Thrombotic thrombocytopenic purpura cases after CoronaVac raise concerns over vaccine safety

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

8 Nov 2024

SARS CoV 2 News and Research

Researchers explore the power of podcasts in fighting infectious disease misinformation

WHO and partners announce grants to boost pathogen genomic surveillance

Boosters cut long COVID risk significantly

Barcelona launches world’s first joint program on evolutionary medical genomics

Researchers uncover hidden roles of accessory genes in SARS-CoV-2

New approach to stabilize RSV protein could lead to better vaccines

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

Genomic surveillance could revolutionize the fight against antimicrobial resistance

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

Pandemic linked to 16% rise in babies born with heart defects

Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies

FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Next-generation metagenomic sequencing test quickly detects any kind of pathogen

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

AI tool enhances diagnosis of long COVID in electronic health records

Thrombotic thrombocytopenic purpura cases after CoronaVac raise concerns over vaccine safety

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News